Steven Cohen Edwards Lifesciences Corp Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,468,733 shares of EW stock, worth $115 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,468,733

Previous 588,206 149.7%

Holding current value

$115 Million

Previous $43.5 Million 144.47%

% of portfolio

0.27%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $59.8 Million - $67.1 Million	880,527 Added 149.7%	1,468,733 $106 Million
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $38 Million - $44.7 Million	588,206 New	588,206 $43.5 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $213 Million - $238 Million	-2,526,642 Reduced 85.05%	444,162 $41 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $216 Million - $284 Million	2,970,804 New	2,970,804 $284 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.54 Million - $2.07 Million	22,199 New	22,199 $1.54 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $28,590 - $32,536	385 New	385 $31,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $48.6 Million - $60.7 Million	-579,142 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $45.6 Million - $52.5 Million	579,142 New	579,142 $48.4 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $8.56 Million - $10.9 Million	-119,415 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $24.7 Million - $32.1 Million	-367,269 Reduced 75.46%	119,415 $9.53 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $23.4 Million - $31.2 Million	405,835 Added 501.97%	486,684 $33.6 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $2.87 Million - $4.43 Million	54,704 Added 209.23%	80,849 $15.3 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $1.81 Million - $2.08 Million	-25,296 Reduced 49.17%	26,145 $6.1 Million
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $2.46 Million - $3.02 Million	40,040 Added 351.2%	51,441 $11.3 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $2.43 Million - $2.81 Million	-43,619 Reduced 79.28%	11,401 $2.11 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $535,410 - $716,079	-11,180 Reduced 16.89%	55,020 $10.5 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $2.86 Million - $3.51 Million	61,600 Added 1339.13%	66,200 $10.1 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $210,220 - $266,938	4,600 New	4,600 $801,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $8.49 Million - $10.3 Million	-200,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $2.6 Million - $3.32 Million	70,000 Added 53.85%	200,000 $27.9 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $11.6 Million - $13.6 Million	-344,495 Reduced 72.6%	130,000 $14.7 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $17.2 Million - $18.4 Million	474,495	474,495 $51.9 Million

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

487M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account